Molecular Partners successfully placed 5'528'089 new shares to institutional investors by way of an accelerated book-building process in a private placement. The offer price was set at CHF 14.50 per share. The gross proceeds from the placement amounted to CHF 80.2 million. The proceeds from the capital increase will be used to fund research & development activities as well as for general corporate purposes.

SVB Leerink LLC, Cowen and Company, LLC, Van Lanschot Kempen Wealth Management N.V. and Credit Suisse AG acted as Joint Bookrunners.

Bär & Karrer acted as legal counsel to the banking syndicate. The team included Thomas Reutter, Alexander von Jeinsen, Annette Weber and Audrey Benzow (all Capital Markets). Molecular Partners successfully placed 5'528'089 new shares to institutional investors by way of an accelerated book-building process in a private placement. The offer price was set at CHF 14.50 per share. The gross proceeds from the placement amounted to CHF 80.2 million. The proceeds from the capital increase will be used to fund research & development activities as well as for general corporate purposes.

SVB Leerink LLC, Cowen and Company, LLC, Van Lanschot Kempen Wealth Management N.V. and Credit Suisse AG acted as Joint Bookrunners.

Bär & Karrer acted as legal counsel to the banking syndicate. The team included Thomas Reutter, Alexander von Jeinsen, Annette Weber and Audrey Benzow (all Capital Markets).